WHO grants emergency use of China's Sinovac COVID Vaccine
ABP News Bureau
Updated at:
02 Jun 2021 10:22 AM (IST)
Download ABP Live App and Watch All Latest Videos
View In AppIn a recent development, the World Health Organisation has granted an emergency use for the COVID-19 vaccine made by the Chinese company Sinovac. The vaccine will be used for adults 18years and older, in a two-dose schedule with a spacing of two to four weeks. Meanwhile, last month, Sinopharm became the first Chinese vaccine to be approved by the WHO.